{"protocolSection":{"identificationModule":{"nctId":"NCT06482398","orgStudyIdInfo":{"id":"COA 0087/2024"},"organization":{"fullName":"Chulalongkorn University","class":"OTHER"},"briefTitle":"Cream Containing Sericin and Turmeric in Psoriasis Patients","officialTitle":"Efficacy and Safety of Cream Containing Sericin and Turmeric in Psoriasis Patients"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-07-01","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2025-06-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-07-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-21","studyFirstSubmitQcDate":"2024-06-28","studyFirstPostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2024-06-28","lastUpdatePostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Pornanong Aramwit, Pharm.D., Ph.D","investigatorTitle":"Professor","investigatorAffiliation":"Chulalongkorn University"},"leadSponsor":{"name":"Chulalongkorn University","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Psoriasis lesion is divided into two parts. Half of the lesion will apply cream containing sericin and turmeric and another will apply steroid cream (control). The samples will be apply two times a day for 8 weeks. Psoriasis area and severity index, physician global assessment, body surface area of lesion, dermatology life quality index, Itching score, adverse reaction are evaluated before, after using the samples for 4 and 8 weeks."},"conditionsModule":{"conditions":["Psoriasis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":30,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Sericin extract and turmeric extract cream","type":"EXPERIMENTAL","description":"Apply the sample 2 times a day for 8 weeks","interventionNames":["Drug: Sericin extract and turmeric extract cream"]},{"label":"Triamcinolone acetonide 1% cream","type":"ACTIVE_COMPARATOR","description":"Apply the sample 2 times a day for 8 weeks","interventionNames":["Drug: Triamcinolone acetonide 1% Cream"]}],"interventions":[{"type":"DRUG","name":"Sericin extract and turmeric extract cream","description":"Apply the sample 2 times a day for 8 weeks","armGroupLabels":["Sericin extract and turmeric extract cream"]},{"type":"DRUG","name":"Triamcinolone acetonide 1% Cream","description":"Apply the sample 2 times a day for 8 weeks","armGroupLabels":["Triamcinolone acetonide 1% cream"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Psoriasis Area and Severity Index","description":"Physician will evaluate the psoriasis lesion using Psoriasis Area and Severity Index. The score is graded 0 to 72 (low score means less severity and high score means high severity).","timeFrame":"8 weeks"}],"secondaryOutcomes":[{"measure":"Physician Global Assessment","description":"Physician will evaluate the psoriasis lesion using Physician Global Assessment score (0 to 6, 0 means completely cleared, except for possible residual nonerythematous discoloration and 6 means condition worsened).","timeFrame":"8 weeks"},{"measure":"Body surface area of lesion","description":"Physician will evaluate body surface area of psoriasis lesion in percentage. (low percentage means the lesion area decrease and high percentage means the lesion area increase).","timeFrame":"8 weeks"},{"measure":"Dermatology Life Quality Index","description":"Patients will assess dermatology life quality score (0 to 30, 0 means high life quality and 30 means low life quality).","timeFrame":"8 weeks"},{"measure":"Itching score","description":"Patients will assess itching score using visual analogue scale (0 to 10, 0 means low severity and 10 means high severity).","timeFrame":"8 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age over 18 years\n* Patients with body surface area of psoriasis lesion less than 10, have psoriasis area and severity index less than 10 , and no lesion at face, hands,feet, and genital area\n* No topical application on psoriasis lesion at least 2 weeks\n* Willing to attend the study\n\nExclusion Criteria:\n\n* Uncontrolled diseases\n* Allergic to sericin turmeric and steroid\n* Other skin diseases\n* Pregnancy and lactation","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000011565","term":"Psoriasis"}],"ancestors":[{"id":"D000017444","term":"Skin Diseases, Papulosquamous"},{"id":"D000012871","term":"Skin Diseases"}],"browseLeaves":[{"id":"M14422","name":"Psoriasis","asFound":"Psoriasis","relevance":"HIGH"},{"id":"M15674","name":"Skin Diseases","relevance":"LOW"},{"id":"M19713","name":"Skin Diseases, Papulosquamous","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC17","name":"Skin and Connective Tissue Diseases"},{"abbrev":"All","name":"All Conditions"}]},"interventionBrowseModule":{"meshes":[{"id":"D000014221","term":"Triamcinolone"},{"id":"D000014222","term":"Triamcinolone Acetonide"},{"id":"C000005900","term":"Triamcinolone hexacetonide"},{"id":"C000030262","term":"Triamcinolone diacetate"},{"id":"C000012596","term":"Turmeric extract"}],"ancestors":[{"id":"D000000893","term":"Anti-Inflammatory Agents"},{"id":"D000005938","term":"Glucocorticoids"},{"id":"D000006728","term":"Hormones"},{"id":"D000006730","term":"Hormones, Hormone Substitutes, and Hormone Antagonists"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000007166","term":"Immunosuppressive Agents"},{"id":"D000007155","term":"Immunologic Factors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000000975","term":"Antioxidants"},{"id":"D000020011","term":"Protective Agents"}],"browseLeaves":[{"id":"M16974","name":"Triamcinolone","asFound":"Sham Comparator","relevance":"HIGH"},{"id":"M16975","name":"Triamcinolone Acetonide","asFound":"Insomnia","relevance":"HIGH"},{"id":"M237966","name":"Triamcinolone hexacetonide","asFound":"Insomnia","relevance":"HIGH"},{"id":"M209573","name":"Triamcinolone diacetate","asFound":"Insomnia","relevance":"HIGH"},{"id":"M342247","name":"Turmeric extract","asFound":"JNJ-56136379","relevance":"HIGH"},{"id":"M4217","name":"Anti-Inflammatory Agents","relevance":"LOW"},{"id":"M9047","name":"Glucocorticoids","relevance":"LOW"},{"id":"M9789","name":"Hormones","relevance":"LOW"},{"id":"M9788","name":"Hormone Antagonists","relevance":"LOW"},{"id":"M10212","name":"Immunosuppressive Agents","relevance":"LOW"},{"id":"M10201","name":"Immunologic Factors","relevance":"LOW"},{"id":"M7951","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M4292","name":"Antioxidants","relevance":"LOW"},{"id":"M21869","name":"Protective Agents","relevance":"LOW"},{"id":"T319","name":"Turmeric","asFound":"Unable to","relevance":"HIGH"}],"browseBranches":[{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"HB","name":"Herbal and Botanical"}]}},"hasResults":false}